https://sputnikglobe.com/20220831/india-to-launch-first-homegrown-vaccine-against-cervical-cancer-1100216551.html
India to Launch First Homegrown Vaccine Against Cervical Cancer
India to Launch First Homegrown Vaccine Against Cervical Cancer
Sputnik International
According to the World Health Organization (WHO), cervical cancer is the fourth most common cancer among women globally, with an estimated 604,000 new cases... 31.08.2022, Sputnik International
2022-08-31T14:35+0000
2022-08-31T14:35+0000
2022-08-31T14:35+0000
india
vaccine
vaccine
cervical cancer
vaccination
immunization
https://cdn1.img.sputnikglobe.com/img/101961/03/1019610370_0:190:3600:2215_1920x0_80_0_0_5a5563b3f24098f9263f8fa4dd7f0d34.jpg
India is set to launch its first domestically developed "Quadrivalent Human Papillomavirus Vaccine" (qHPV) on Thursday.Union Minister of State (Independent Charge) for Science and Technology Jitendra Singh will unveil the vaccine, developed by the world's largest vaccine manufacturer - the Serum Institute of India (SII) and the Ministry of Science and Technology's Department of Biotechnology (DBT).The vaccine can also be administered to children, Dr. N.K. Arora, chairperson of the COVID working group at the National Technical Advisory Group on Immunization (NTAGI), told the media.Amid the shortage of vaccines on the global market, Dr. Arora feels that with the new Made-in-India vaccine to treat cervical cancer, the country will be able to meet the requirements and fulfill the supply gap.
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
2022
Sangeeta Yadav
https://cdn1.img.sputnikglobe.com/img/07e4/08/1b/1080292803_0:121:960:1081_100x100_80_0_0_7490b319dab9611e309056b177265184.jpg
Sangeeta Yadav
https://cdn1.img.sputnikglobe.com/img/07e4/08/1b/1080292803_0:121:960:1081_100x100_80_0_0_7490b319dab9611e309056b177265184.jpg
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
Sangeeta Yadav
https://cdn1.img.sputnikglobe.com/img/07e4/08/1b/1080292803_0:121:960:1081_100x100_80_0_0_7490b319dab9611e309056b177265184.jpg
india, vaccine, vaccine, cervical cancer, vaccination, immunization
india, vaccine, vaccine, cervical cancer, vaccination, immunization
India to Launch First Homegrown Vaccine Against Cervical Cancer
According to the World Health Organization (WHO), cervical cancer is the fourth most common cancer among women globally, with an estimated 604,000 new cases and 342,000 deaths in 2020. As per the Centers for Disease Control and Prevention, all women are at risk of cervical cancer and it occurs mostly in those aged above 30.
India is set to launch its first domestically developed "Quadrivalent Human Papillomavirus Vaccine" (qHPV) on Thursday.
Union Minister of State (Independent Charge) for Science and Technology Jitendra Singh will unveil the vaccine, developed by the world's largest vaccine manufacturer - the Serum Institute of India (SII) and the Ministry of Science and Technology's Department of Biotechnology (DBT).
The vaccine can also be administered to children, Dr. N.K. Arora, chairperson of the COVID working group at the National Technical Advisory Group on Immunization (NTAGI), told the media.
"It (qHPV) is very effective and prevents cervical cancer because, 85 to 90 percent cases, cervical cancer is because of this particular virus and this vaccine is against those viruses. So, if we give it to our young children and daughters, they are protected from the infection and consequently probably 30 years later, cancer doesn't occur," Dr. Arora explained.
Amid the shortage of vaccines on the global market, Dr. Arora feels that with the new Made-in-India vaccine to treat cervical cancer, the country will be able to meet the requirements and fulfill the supply gap.
